CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionCurrent ratio is 8.43×, higher than 95% of its Medical Instruments & Supplies peers (median 2.98×)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.92%
Annual Rate
CNY 0.46Paid annual
Payout Ratio
26.0%Sustainable
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.53BCNY1.12B · vs all stocks (USD)
Trailing P/E
42.79xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.09BCNY161.42M · vs all stocks (USD)
Profit Margin
18.70%vs Medical Instruments & Supplies peers
Beta
0.9150xvs all stocks
52-Week Change
39.52%vs all stocks
Market Capitalization
7.53BCNY1.12B · vs all stocks (USD)
Enterprise Value
6.99BCNY1.04B · vs all stocks (USD)
Trailing P/E
42.79xvs Medical Instruments & Supplies peers
Forward P/E
17.71xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
7.52xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.77xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.43xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
30.47xvs Medical Instruments & Supplies peers
Gross Margin
55.97%vs Medical Instruments & Supplies peers
Profit Margin
18.70%vs Medical Instruments & Supplies peers
Operating Margin
19.24%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.07%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
9.63%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.09BCNY161.42M · vs all stocks (USD)
Revenue per Share (TTM)
6.79CNYUpdated Aug 20, 2026Quarterly Revenue Growth
25.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
573.49MCNY85.17M · vs all stocks (USD)
EBITDA (TTM)
216.86MCNY32.21M · vs all stocks (USD)
Net Income (TTM)
203.20MCNY30.18M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
22.30%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
257.91MCNY38.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-59.98MCNY-8.91M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4600CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.92%vs all stocks
Payout Ratio
25.96%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
13.34MCNYFY2025 · Dec 31, 2025Revenue
1.03BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
490.97MCNYFY2025 · Dec 31, 2025Gross Profit
543.81MCNYFY2025 · Dec 31, 2025Operating Income
186.78MCNY27.74M · vs all stocks (USD)
Pre-tax Income
216.18MCNYFY2025 · Dec 31, 2025Income Tax Expense
19.88MCNYFY2025 · Dec 31, 2025Net Income
196.29MCNYFY2025 · Dec 31, 2025EBIT
216.65MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
259.86MCNYFY2025 · Dec 31, 2025Research & Development
73.59MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
116.74MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.77MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
467.10KCNYFY2025 · Dec 31, 2025EPS (Basic)
1.31CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.31CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
149.30MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
149.30MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
196.29MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-75.21KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
197.43MCNYFY2025 · Dec 31, 2025Free Cash Flow
131.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
245.00MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
196.29MCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.61MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-12.06MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
7.58MCNYFY2025 · Dec 31, 2025Capital Expenditures
-66.25MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.93BCNYFY2025 · Dec 31, 2025Sale of Investments
3.34BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-661.44MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.50MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-270.00KCNYFY2025 · Dec 31, 2025Common Dividends Paid
-49.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.84MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-54.11MCNYFY2025 · Dec 31, 2025Shares Outstanding
149.19MSharesUpdated Aug 20, 2026Float Shares
140.28MSharesUpdated Aug 20, 2026% Held by Insiders
48.07%vs all stocks
% Held by Institutions
9.27%vs all stocks
Total Cash (MRQ)
1.41BCNY210.00M · vs all stocks (USD)
Total Cash per Share (MRQ)
9.48CNYUpdated Aug 20, 2026Total Debt (MRQ)
12.05MCNY1.79M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0055xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
8.43xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
14.54CNYUpdated Aug 20, 2026Total Assets
2.46BCNY365.84M · vs all stocks (USD)
Total Current Assets
2.03BCNYFY2025 · Dec 31, 2025Total Liabilities
312.78MCNYFY2025 · Dec 31, 2025Total Non-current Assets
436.44MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
63.78MCNYFY2025 · Dec 31, 2025Total Current Liabilities
248.99MCNYFY2025 · Dec 31, 2025Cash
241.50MCNYFY2025 · Dec 31, 2025Cash Equivalents
7.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
249.02MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.21BCNYFY2025 · Dec 31, 2025Accounts Receivable
201.24MCNYFY2025 · Dec 31, 2025Inventory
141.75MCNYFY2025 · Dec 31, 2025Accounts Payable
147.16MCNYFY2025 · Dec 31, 2025Short-term Debt
5.16MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.53MCNYFY2025 · Dec 31, 2025Long-term Debt
7.42MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
36.15MCNYFY2025 · Dec 31, 2025Common Stock (Book)
106.56MCNYFY2025 · Dec 31, 2025Retained Earnings
675.19MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.15BCNY319.39M · vs all stocks (USD)
52-Week Low
29.77CNYUpdated Aug 20, 202652-Week High
87.98CNYUpdated Aug 20, 202652-Week Change
39.52%vs all stocks
Beta
0.9150xvs all stocks
50-Day MA
54.94CNYUpdated Aug 20, 2026200-Day MA
46.00CNYUpdated Aug 20, 2026Avg 10-Day Volume
7.64MSharesUpdated Aug 20, 2026Avg 30-Day Volume
8.14MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
1.28CNYUpdated Aug 20, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 8.43×, higher than 95% of its Medical Instruments & Supplies peers (median 2.98×)Significant
Current ratio: 8.43Industry median: 2.98Industry P95: 8.21Peers compared: 35.00
Debt-to-equity is 0.01×, lower than 95% of its Medical Instruments & Supplies peers (median 0.16×)Notable
Debt-to-equity: 0.01Industry median: 0.16Industry P5: 0.01Peers compared: 35.00
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Foshan Electrical and Lighting Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Batisoke Cimento Sanayi ve Ticaret A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
U.S. Physical Therapy Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Kingsignal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Asia-Pacific Mechanical & Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Shijia Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shenzhen AV-Display Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tobii Dynavox AB
Tier 1ProductionThroughput-Bound ConversionRule
Nutex Health Inc.
Tier 1ProductionThroughput-Bound ConversionRuleInterface
Gerresheimer AG
Tier 1ProductionThroughput-Bound ConversionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Medlive Technology Co. Ltd.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLow-Leverage Liquidity Configuration
Anhui XDLK Microsystems Co., Ltd.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLow-Leverage Liquidity Configuration
Shenzhen Yanmade Technology Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLow-Leverage Liquidity Configuration